Université de Sherbrooke and Nestlé Health Science have announced a partnership to further research in the area of ketotherapeautics. Néstle has invested $1M in the establishment of a Clinical Research Chair in Ketotherapeautics at the university. “We will use the BENEFIC results to further research on the potential benefits of ketones in neurodegenerative disorders,” said USherbrooke Professor Stephen Cunnane, who will be the first holder of the research chair. “I am extremely proud of this partnership. This new research chair could help lessen the devastating impact that brain disorders have on the quality of life of many older people.” USherbrooke| USherbrooke (PDF, EN) Note: Archived stories may contain dead links or be missing source links.